Amy E. McKee - Sep 20, 2021 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
Director
Signature
/s/ Jessica Dickerson, by power of attorney
Stock symbol
BCRX
Transactions as of
Sep 20, 2021
Transactions value $
$0
Form type
4
Date filed
9/22/2021, 04:15 PM
Next filing
Jun 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCRX Non-Qualified Stock Option Award $0 +53.3K $0.00 53.3K Sep 20, 2021 Common Stock 53.3K $15.02 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan.
F2 The option vests 1/36 per month for a period of 36 months, beginning on October 20, 2021